Methyl 4-(acetoxymethyl)benzoate
CAS: 27548-25-0
Ref. 3D-CBA54825
| 1g | Discontinued | ||
| 5g | Discontinued | ||
| 10g | Discontinued | ||
| 25g | Discontinued | ||
| 500mg | Discontinued |
Product Information
Methyl 4-(acetoxymethyl)benzoate is an antileishmanial agent that inhibits the growth of Leishmania parasites. It has been shown to have bacteriostatic activity against a range of Gram-negative bacteria including Salmonella and Escherichia coli, but no antibacterial activity against Gram-positive bacteria. Methyl 4-(acetoxymethyl)benzoate's mechanism of action is unknown, but it may inhibit the synthesis of hepg2, which is a cellular protein that is important for the production of adriamycin. This drug also has a competitive effect on adriamycin and ent-kaurene binding to their respective receptors.
Methyl 4-(acetoxymethyl)benzoate binds to bacterial DNA gyrase and topoisomerase IV, which are enzymes that maintain the integrity of bacterial DNA. It binds to bacterial 16S ribosomal RNA and inhibits protein synthesis, leading to cell death by
